Amcor receives China lab accreditation for global market access
Get Alerts AMCR Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 4.4%
EPS Growth %: +495.0%
Join SI Premium – FREE
Amcor (NYSE: AMCR) announced its Asia Pacific Innovation Center laboratory in China has received accreditation from the China National Accreditation Service for Conformity Assessment.
The accreditation allows the packaging company's laboratory to generate test data recognized across 116 countries, according to the company's press release statement. CNAS serves as China's national accreditation body for testing and calibration laboratories, following international standards for technical competence and quality management.
The certification process required an 18-to-24-month evaluation period. With the accreditation, Amcor's laboratory can now provide data validation that streamlines regulatory approval and market access for customers operating internationally.
"Becoming CNAS accredited means our customers don't have to second-guess the data — it's recognized wherever they operate," said Ludmila Fidale, Vice President of Research and Development at Amcor.
The accreditation enables the laboratory to accelerate compliance pathways for multinational and regional customers, develop certification approaches for emerging markets, and deliver data-driven innovation supporting packaging performance.
Amcor operates over 400 locations in more than 40 countries and employs over 75,000 people. The company generates $23 billion in annualized sales from its packaging solutions business across nutrition, health, beauty and wellness categories.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Arvinas CMO to depart in July as company begins search
- A.O. Smith executive chairman to retire, CEO to assume chairman role
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share